News Release Detail
Mylan Completes Acquisition of Cold-EEZE® Brand
The transaction provides Mylan all assets and rights relating to the Cold-EEZE® brand, including all
Mylan CEO Heather Bresch commented, "The completion of this transaction is an important step as we continue to expand our consumer healthcare offerings. Cold-EEZE® is now Mylan's largest
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We market a growing portfolio of approximately 7,500 products around the world, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-completes-acquisition-of-cold-eeze-brand-300431410.html
SOURCE
News Provided by Acquire Media